Question types

Start with

Question limit

of 60 available terms

Print test

5 Written questions

5 Matching questions

  1. 2422.04
  2. 2407.02
  3. 2420
  4. 2422
  5. 2404.03
  1. a Replacement or Supplemental of Deposit
  2. b The Requirement for a Computer Readable Copy of the Offical Copy of the Sequence Listing
  3. c Reference to a Deposit in the Specification

    a reference to a biological material, present in an application upon filing, may form the basis for making a deposit, where required, after the filing date of a given application but that the reference to the biological material, itself, cannot be added after filing without risking the prohibited introduction of new matter (35 U.S.C. 132). See the discussion of the Lundak application in MPEP ยง 2406.01. - See more at:
  4. d Nucleotide and/or Amino Acid Sequence Disclosures in Patent Disclosure in Patent Applications
  5. e The Requirement for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures-the Sequence

5 Multiple choice questions

  1. Certification of Statement of Availability of Deposit
  2. Examination Procedures
  3. Summary of the Requirement of the Sequence Rules
  4. 2500
  5. The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures

5 True/False questions

  1. 2423Requirements for Nucleotide and/or Amino Acid Sequences as Part of the Application Papers


  2. 2421.01Application Affected

    The sequence rules require the use of standard symbols and a standard format for sequence data in most sequence-type patent applications. They further require the submission of that data in computer readable form. Compliance is required for most disclosures of sequence data in new applications filed on or after October 1, 1990.


  3. 2411.04After Patent Has Been Granted


  4. 2411.01After Patent Has Been Granted


  5. 2403.01Description in Application Specification
    37 CFR 1.804(a)
    requirement for a specific identification consistent with the description requirement of the first paragraph of 35 U.S.C. 112 and provides an antecedent basis for the biological material which either has been or will be deposited before the patent is granted.